CXCL16 silencing alleviates hepatic ischemia reperfusion injury during liver transplantation by inhibiting p38 phosphorylation.

CXCL16 silencing alleviates hepatic ischemia reperfusion injury during liver transplantation by inhibiting p38 phosphorylation.

Model: Hepatic ischaemia-reperfusion injury during liver transplantation; in vitro oxygen-glucose deprivation and reoxygenation in AML12 hepatocytes

Silencing CXCL16 reduced CXCR6 expression, hepatocyte apoptosis and hepatic injury, and the protection was reversed by activation of p38 phosphorylation.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.